Orchard Therapeutics plc
ORTX · NASDAQ
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $23 | $38 | $61 | $68 |
| Short-Term Investments | $102 | $112 | $85 | $75 |
| Receivables | $14 | $18 | $8 | $14 |
| Inventory | $7 | $7 | $6 | $3 |
| Other Curr. Assets | $7 | $6 | $6 | $7 |
| Total Curr. Assets | $154 | $181 | $166 | $168 |
| Property Plant & Equip (Net) | $27 | $29 | $30 | $31 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $3 | $3 | $4 | $4 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $7 |
| Other NC Assets | $18 | $19 | $17 | $9 |
| Total NC Assets | $48 | $51 | $51 | $51 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $202 | $232 | $217 | $219 |
| Liabilities | – | – | – | – |
| Payables | $4 | $7 | $9 | $9 |
| Short-Term Debt | $15 | $16 | $16 | $16 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $1 | $1 | $1 | $1 |
| Other Curr. Liab. | $30 | $34 | $28 | $34 |
| Total Curr. Liab. | $49 | $58 | $53 | $61 |
| LT Debt | $33 | $34 | $37 | $42 |
| Deferred Rev, NC | $10 | $11 | $11 | $10 |
| Deferred Tax Liab, NC | $21 | $12 | $0 | $0 |
| Other NC Liab. | $8 | $8 | $14 | $8 |
| Total NC Liab. | $73 | $66 | $62 | $60 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $122 | $123 | $115 | $121 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $29 | $29 | $24 | $16 |
| Retained Earnings | -$966 | -$931 | -$918 | -$901 |
| AOCI | $23 | $19 | $20 | $26 |
| Other Equity | $994 | $992 | $976 | $957 |
| Total Equity | $80 | $109 | $102 | $98 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $202 | $232 | $217 | $219 |
| Net Debt | $24 | $12 | -$8 | -$10 |